These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9666905)

  • 1. Early detection of changes in visual function in diabetes mellitus.
    Ismail GM; Whitaker D
    Ophthalmic Physiol Opt; 1998 Jan; 18(1):3-12. PubMed ID: 9666905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the colour vision and contrast sensitivity in diabetic patients without retinopathy].
    Malukiewicz G; Lesiewska-Junk H; Kaźmierczak K
    Klin Oczna; 2009; 111(7-9):221-3. PubMed ID: 19899578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of color vision disturbances in diagnostics of early diabetic retinopathy].
    Mulak M; Reniewska B; Kostuś E; Balcewicz A; Misiuk-Hojło M
    Klin Oczna; 2002; 104(3-4):249-51. PubMed ID: 12608311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduction of retinal light sensitivity in diabetic patients].
    Pahor D
    Klin Monbl Augenheilkd; 2003 Dec; 220(12):868-72. PubMed ID: 14704945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening of early color vision loss in diabetic patients].
    Peduzzi M; Longanesi L; Ascari A; Cascione S; Galletti M; Roncaia R; Pacchioni C; Maione M
    J Fr Ophtalmol; 1989; 12(11):791-6. PubMed ID: 2639899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent substitution S-cone electroretinogram in subjects with diabetes mellitus.
    Mortlock KE; Chiti Z; Drasdo N; Owens DR; North RV
    Ophthalmic Physiol Opt; 2005 Sep; 25(5):392-9. PubMed ID: 16101944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of chromatic sensitivity in AMD and diabetes: a comparative study.
    O'Neill-Biba M; Sivaprasad S; Rodriguez-Carmona M; Wolf JE; Barbur JL
    Ophthalmic Physiol Opt; 2010 Sep; 30(5):705-16. PubMed ID: 20883358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnsworth-Munsell 100-hue test for patients with diabetes mellitus.
    Utku D; Atmaca LS
    Ann Ophthalmol; 1992 Jun; 24(6):205-8. PubMed ID: 1444079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy.
    Jackson GR; Scott IU; Quillen DA; Walter LE; Gardner TW
    Br J Ophthalmol; 2012 May; 96(5):699-703. PubMed ID: 22174096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normative contrast sensitivity values for the back-lit Melbourne Edge Test and the effect of visual impairment.
    Eperjesi F; Wolffsohn J; Bowden J; Napper G; Rubinstein M
    Ophthalmic Physiol Opt; 2004 Nov; 24(6):600-6. PubMed ID: 15491489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatic-contrast threshold impairment in diabetes.
    Tregear SJ; Knowles PJ; Ripley LG; Casswell AG
    Eye (Lond); 1997; 11 ( Pt 4)():537-46. PubMed ID: 9425421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early disorders of retinal function in diabetes mellitus].
    Gallasch G; Krastel H; Hofmeister S
    Ophthalmologe; 1992 Oct; 89(5):395-9. PubMed ID: 1304220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for sight-threatening diabetic retinopathy: comparison of fundus photography with automated color contrast threshold test.
    Ong GL; Ripley LG; Newsom RS; Cooper M; Casswell AG
    Am J Ophthalmol; 2004 Mar; 137(3):445-52. PubMed ID: 15013866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hue discrimination and S cone pathway sensitivity in early diabetic retinopathy.
    Greenstein V; Sarter B; Hood D; Noble K; Carr R
    Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1008-14. PubMed ID: 2354907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual acuity in a population with regular screening for type 2 diabetes mellitus and eye disease.
    Olafsdottir E; Andersson DK; Stefánsson E
    Acta Ophthalmol Scand; 2007 Feb; 85(1):40-5. PubMed ID: 17244208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of retinopathy in type 2 diabetes: identification of prognostic parameters for developing visual loss secondary to diabetic maculopathy.
    Hove MN; Kristensen JK; Lauritzen T; Bek T
    Acta Ophthalmol Scand; 2004 Dec; 82(6):679-85. PubMed ID: 15606463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blue-yellow vision deficits in patients with diabetes.
    Rockett M; Anderle D; Bessman AN
    West J Med; 1987 Apr; 146(4):431-3. PubMed ID: 3495070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of visual functions in young insulin dependent diabetics.
    Banford D; North RV; Dolben J; Butler G; Owens DR
    Ophthalmic Physiol Opt; 1994 Oct; 14(4):339-46. PubMed ID: 7845689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal Cambridge low-contrast grating sensitivity results associated with diabetic retinopathy as a potential screening tool.
    Abrishami M; Heravian J; Derakhshan A; Mousavi M; Banaee T; Daneshvar R; Moghaddam HO
    East Mediterr Health J; 2007; 13(4):810-8. PubMed ID: 17955763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetes and color vision disorder detected by the Farnsworth 100 Hue test. Diabetic dyschromatopsia].
    Ayed S; Jeddi A; Kallal Z
    J Fr Ophtalmol; 1990; 13(10):506-10. PubMed ID: 2081841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.